Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Faculty

Richard M. Bergenstal, MD

Executive Director
International Diabetes Center – HealthPartners Institute
Minneapolis, Minnesota, United States

Disclosures

Richard M. Bergenstal, MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care; Ascencia; Bigfoot Biomedical, Inc.; CeQur; Dexcom, Eli Lilly; Hygieia; Medtronic, Inc.; Novo Nordisk; Onduo; Roche Diabetes Care; Sanofi; United Healthcare; Zealand Pharma
Research funding from: Abbott Diabetes Care; Dexcom; Eli Lilly; Insulet; Medtronic, Inc.; Novo Nordisk; Sanofi

Revital Nimri, MD

Director
Scientific and Technology Diabetes Service
Institute for Endocrinology and Diabetes
Schneider Children's Medical Center of Israel
Petah Tikva, Israel

Disclosures

Revital Nimri, MD, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Eli Lilly and Company; Novo Nordisk
Research funding from: Abbott Diabetes Care; Dexcom; Insulet Corporation; Medtronic, Inc.

Moshe Phillip, MD

The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes
Schneider Children's Medical Center of Israel
Vice Dean for Research and Development
Sackler Faculty of Medicine
Tel-Aviv University
Petah Tikva, Israel

Disclosures

Moshe Phillip, MD, has the following relevant financial relationships:
Consultant or advisor for: Eli Lilly and Company; Insulet Corporation; Medtronic, Inc.; Novo Nordisk; Pfizer, Inc.; Qulab Medical; Sanofi
Speaker or member of speakers bureau for: Eli Lilly and Company; Medtronic, Inc.; Novo Nordisk; Pfizer, Inc.; Sanofi
Research funding from: Debiopharm; Dexcom; Eli Lilly and Company; Gwave; Insulet Corporation; Lumos Pharma; Medtronic, Inc.; NG Solutions; Novo Nordisk; OPKO Health Inc; Pfizer, Inc.; Roche; Sanofi
Royalties from: NG Solutions
Stock options from: NG Solutions
Ownership interest: NG Solutions

Tadej Battelino, MD, PhD

Department of Pediatric Endocrinology
Diabetes and Metabolic Diseases
UMC - University Children’s Hospital
Faculty of Medicine
University of Ljubljana
Ljubljana, Slovenia

Disclosures

Tadej Battelino, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Indigo Diabetes; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: Abbott Diabetes Care; AstraZeneca; Aventis Pharmaceuticals, Inc.; Eli Lilly and Company; Medtronic, Inc.; Novo Nordisk; Roche; Sanofi
Research funding from: Abbott Diabetes Care; GluSense; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk; Sandoz; Sanofi; Zealand Pharma

Editors

Anne G. Le, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Anne G. Le, PharmD, has no relevant financial relationships.

Frederick Stange, DO

Scientific Content Manager, Medscape, LLC

Disclosures

Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME / ABIM MOC / CE

New Automated Insulin Delivery Recommendations Coming in HOT!

Authors: Richard M. Bergenstal, MD; Tadej Battelino, MD, PhD; Revital Nimri, MD; Moshe Phillip, MD
CME / ABIM MOC / CE Released: 1/30/2023
Valid for credit through: 1/30/2024

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 0.50 ABIM MOC points

Nurses - 0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for diabetologists, endocrinologists, primary care physicians, nurses, nurse practitioners, pharmacists, and obstetricians and gynecologists.

The goal of this activity is for learners to be better able to improve understanding of automated insulin delivery (AID) and the new 2022 consensus recommendations on the use of AID technologies in clinical practice.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- New AID recommendations from Advanced Technologies & Treatments for Diabetes (ATTD)
- New AID ambulatory glucose profile
- Patient selection for use of AID

Disclosures

Disclosures for additional planners can be found here.

Faculty

Richard M. Bergenstal, MD

Executive Director
International Diabetes Center – HealthPartners Institute
Minneapolis, Minnesota, United States

Disclosures

Richard M. Bergenstal, MD, has the following relevant financial relationships:
Consultant or advisor for: Abbott Diabetes Care; Ascencia; Bigfoot Biomedical, Inc.; CeQur; Dexcom, Eli Lilly; Hygieia; Medtronic, Inc.; Novo Nordisk; Onduo; Roche Diabetes Care; Sanofi; United Healthcare; Zealand Pharma
Research funding from: Abbott Diabetes Care; Dexcom; Eli Lilly; Insulet; Medtronic, Inc.; Novo Nordisk; Sanofi

Revital Nimri, MD

Director
Scientific and Technology Diabetes Service
Institute for Endocrinology and Diabetes
Schneider Children's Medical Center of Israel
Petah Tikva, Israel

Disclosures

Revital Nimri, MD, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Eli Lilly and Company; Novo Nordisk
Research funding from: Abbott Diabetes Care; Dexcom; Insulet Corporation; Medtronic, Inc.

Moshe Phillip, MD

The Jesse Z. and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes
Schneider Children's Medical Center of Israel
Vice Dean for Research and Development
Sackler Faculty of Medicine
Tel-Aviv University
Petah Tikva, Israel

Disclosures

Moshe Phillip, MD, has the following relevant financial relationships:
Consultant or advisor for: Eli Lilly and Company; Insulet Corporation; Medtronic, Inc.; Novo Nordisk; Pfizer, Inc.; Qulab Medical; Sanofi
Speaker or member of speakers bureau for: Eli Lilly and Company; Medtronic, Inc.; Novo Nordisk; Pfizer, Inc.; Sanofi
Research funding from: Debiopharm; Dexcom; Eli Lilly and Company; Gwave; Insulet Corporation; Lumos Pharma; Medtronic, Inc.; NG Solutions; Novo Nordisk; OPKO Health Inc; Pfizer, Inc.; Roche; Sanofi
Royalties from: NG Solutions
Stock options from: NG Solutions
Ownership interest: NG Solutions

Tadej Battelino, MD, PhD

Department of Pediatric Endocrinology
Diabetes and Metabolic Diseases
UMC - University Children’s Hospital
Faculty of Medicine
University of Ljubljana
Ljubljana, Slovenia

Disclosures

Tadej Battelino, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; Indigo Diabetes; Novo Nordisk; Sanofi
Speaker or member of speakers bureau for: Abbott Diabetes Care; AstraZeneca; Aventis Pharmaceuticals, Inc.; Eli Lilly and Company; Medtronic, Inc.; Novo Nordisk; Roche; Sanofi
Research funding from: Abbott Diabetes Care; GluSense; Medtronic, Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk; Sandoz; Sanofi; Zealand Pharma

Editors

Anne G. Le, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Anne G. Le, PharmD, has no relevant financial relationships.

Frederick Stange, DO

Scientific Content Manager, Medscape, LLC

Disclosures

Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For Nurses

Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

Contact This Provider

For Pharmacists

Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-23-073-H01-P).

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Diabetes & Endocrinology

CME / ABIM MOC / CE

New Automated Insulin Delivery Recommendations Coming in HOT!

Authors: Richard M. Bergenstal, MD; Tadej Battelino, MD, PhD; Revital Nimri, MD; Moshe Phillip, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 1/30/2023

Valid for credit through: 1/30/2024

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

Download Now

Earn Credit CME / ABIM MOC / CE Information

Activity Transcript

PDF Downloads

Clinician Handout

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Richard M. Bergenstal, MD

Revital Nimri, MD

Moshe Phillip, MD

Tadej Battelino, MD, PhD

Editors

Anne G. Le, PharmD

Frederick Stange, DO

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Peer Reviewer

CME / ABIM MOC / CE

New Automated Insulin Delivery Recommendations Coming in HOT!

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Richard M. Bergenstal, MD

Revital Nimri, MD

Moshe Phillip, MD

Tadej Battelino, MD, PhD

Editors

Anne G. Le, PharmD

Frederick Stange, DO

Compliance Reviewer/Nurse Planner

Lisa Simani, APRN, MS, ACNP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

For Pharmacists

Instructions for Participation and Credit

New Automated Insulin Delivery Recommendations Coming in HOT!

PDF Downloads